FDA inspection
Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd.: FDA inspection ending Jun 30, 2016
FDA inspection 986262 · No Action Indicated (NAI) · Shijiazhuang
Key facts
| Inspection ID | 986262 |
|---|---|
| Firm | Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd. |
| FEI number | 3010177917 |
| Address | No 136 Huanghe Blvd., 9th Floor, Tech Centre, Hi-tech Dev. Zone |
| City | Shijiazhuang |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Jun 30, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data